All Products
Ketamine occurs as two mirror-image forms: (R)-ketamine and (S)-ketamine. While both interact with NMDA receptors, their balance can influence the character and duration of effects observed in research.
-
(S)-Ketamine (esketamine): Higher NMDA receptor potency; typically yields more pronounced dissociative/psychedelic effects; approved only in specific regulated formulations and settings.
-
(R)-Ketamine (arketamine): Lower NMDA potency; preclinical work suggests longer-duration antidepressant signals and fewer acute dissociative/pressor effects; not approved as a standalone therapy.
- Recommended Dosages:
- Oral: 200–300 mg
- Intranasal: 30–200 mg
All Products
Racemic Ketamine (RUO) — A balanced 50:50 mixture of R- and S-ketamine for glutamatergic research. Ideal for comparative enantiomer studies, NMDA/AMPA and mTOR-linked plasticity work, and circuit-level investigations into dissociation and perception.

